130
PERGUNTAS & RESPOSTAS
RETINOPATIA DIABÉTICA - Novo Paradigma de Cuidados
diabetic macular edema and vitreomacular traction. Ophthalmology
2010;117(6):1087-1093.
26.
Kaiser P, Apte R, Brown D,Reichel E. Managment of diabetic macular
edema. Application of current evidence to patient care. Retina 2012.
Supplement;1-8.
27.
Yeh P-T, Yang C-M, Huang J-S, et al. Vitreous levels of reactive
oxygen species in proliferative diabetic retinopathy. Ophthalmology
2008;115(4):734-737.
28.
Shimura M, Nakazawa T, Yasuda K, et al. Comparative therapy evaluation
of intravitreal bevacizumab and triamcinolone acetonide on persistent
diffuse diabetic macular edema. Am J Ophthalmol 2008;145:854–861.
29.
The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrec-
tomy for severe proliferative diabetic retinopathy in eyes with useful
vision. Results of a randomized trial-Diabetic Retinopathy Vitrectomy
Study Report # 3. Ophthalmology 1988;95:1307–1320.
30.
El-Sabagh H a, Abdelghaffar W, Labib AM, et al. Preoperative intravitreal
bevacizumab use as an adjuvant to diabetic vitrectomy: histopathologic
findings and clínical implications. Ophthalmology 2011;118(4):636-641.
31.
Do DV, Nguyen QD, Boyer D, et al. One-Year Outcomes of the DAVINCI
Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema. Ophthal-
mology. 2012;119(8):1658-1665.